Literature DB >> 1204248

Hydantoin immunosuppression and carcinogenesis.

Y Levo, O Markowitz, N Trainin.   

Abstract

The immunological response of mice submitted to hydantoin treatment was determined. Hydantoin reduced the absolute number of spleen cells in treated animals and did not modify spleen cells reactivity to concanavalin A, although the response to SRBC challenge, as measured by the Jerne plaque-forming cell technique, was significantly decreased. Following these findings, the influence of hydantoin on carcinogenesis was evaluated by using the model of urethane-induced lung adenomas in SWR mice. Treatment with hydantoin significantly reduced the incidence of the induced adenomas. We confirmed that hydantoin modifies the immune response of the host mainly by depressing its humoral function and we have shown that this effect was associated with an inhibitory effect on tumour induction.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1204248      PMCID: PMC1538157     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Influence of immunosuppression and immunorestoration on the formation of urethan-induced lung adenomas.

Authors:  N Trainin; M Linker-Israeli
Journal:  J Natl Cancer Inst       Date:  1970-04       Impact factor: 13.506

Review 2.  IMMUNOLOGICAL FACTORS IN THE PROCESS OF CARCINOGENESIS.

Authors:  M BURNET
Journal:  Br Med Bull       Date:  1964-05       Impact factor: 4.291

Review 3.  Elicitation of selective T and B lymphocyte responses by cell surface binding ligands.

Authors:  M Greaves; G Janossy
Journal:  Transplant Rev       Date:  1972

4.  In vitro cytotoxicity and in vivo tumor enhancement induced by mouse spleen cells autosensitized in vitro.

Authors:  D Ilfeld; C Carnaud; I R Cohen; N Trainin
Journal:  Int J Cancer       Date:  1973-07-15       Impact factor: 7.396

5.  Mechanisms of immunologic enhancement.

Authors:  D B Amos; I Cohen; W J Klein
Journal:  Transplant Proc       Date:  1970-03       Impact factor: 1.066

Review 6.  Immunological enhancement as studied by cell culture techniques.

Authors:  K E Hellström; I Hellström
Journal:  Annu Rev Microbiol       Date:  1970       Impact factor: 15.500

7.  Potential hazards of hydantoin use.

Authors:  J D Easton
Journal:  Ann Intern Med       Date:  1972-12       Impact factor: 25.391

8.  Hydantoin-induced pseudo-pseudolymphoma.

Authors:  R A Gams; J A Neal; F G Conrad
Journal:  Ann Intern Med       Date:  1968-09       Impact factor: 25.391

9.  Enhancement of lung adenoma formation by neonatal thymectomy in mice treated with 7,12-dimethylbenz(a)anthracene or urethan.

Authors:  N Trainin; M Linker-Israeli; M Small; L Boiato-Chen
Journal:  Int J Cancer       Date:  1967-07-15       Impact factor: 7.396

10.  Immunological abnormalities and hydantoins.

Authors:  P J Grob; G E Herold
Journal:  Br Med J       Date:  1972-06-03
View more
  2 in total

1.  Morphological changes in the lymphoid organs induced by diphenylhydantoin sodium (DPH).

Authors:  I G Lorand; W A Hadler; L S Prigenzi
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-11-22

2.  Reduced immunoglobulin concentration and impaired macrophage function in mice due to diphenylhydantoin.

Authors:  J Seager; H M Coovadia; J F Soothill
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.